Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Taylor Ben R. Director active across 1 company, notably Recursion Pharmaceuticals, INC.. Aggregated, 19 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €76k. Activity tracked since 16 December 2024. The latest transaction was disclosed on 17 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Taylor Ben R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
25,018 shares@ US$3.160.0048% mcap7.3% of flowClass A Common StockSEC:0001712276-26-000009:0
48,028 shares@ US$3.1123.8% of flowClass A Common StockSEC:0001712276-26-000003:0
7,075 shares@ US$3.423.6% of flowClass A Common StockSEC:0001712276-26-000002:0
11,908 shares@ US$3.494.0% of flowClass A Common StockSEC:0001601830-26-000020:0
446,279 shares0Class A Common StockSEC:0001601830-26-000013:0
21,383 shares@ US$4.189.1% of flowClass A Common StockSEC:0001712276-25-000017:0
7,057 shares@ US$4.333.4% of flowClass A Common StockSEC:0001712276-25-000015:0
2,271 shares@ US$4.031.1% of flowClass A Common StockSEC:0001712276-25-000013:0
11,908 shares@ US$4.145.9% of flowClass A Common StockSEC:0001712276-25-000011:0
7,057 shares@ US$4.834.2% of flowClass A Common StockSEC:0001601830-25-000147:0
11,908 shares@ US$5.648.8% of flowClass A Common StockSEC:0001601830-25-000133:0
7,057 shares@ US$4.925.2% of flowClass A Common StockSEC:0001601830-25-000091:0
11,908 shares@ US$4.2510.9% of flowClass A Common StockSEC:0001601830-25-000083:0
26,571 shares@ US$5.09530.2% of flowClass A Common StockSEC:0001601830-25-000057:0
7,057 shares@ US$6.8410.7% of flowClass A Common StockSEC:0001601830-25-000049:0
10,879 shares@ US$10.6426.6% of flowClass A Common StockSEC:0001601830-25-000019:0
35,018 shares0Class A Common StockSEC:0001628280-25-004088:0
370,343 shares0Class A Common StockSEC:0001601830-24-000249:0
15,668 shares@ US$6.0421.7% of flowClass A Common StockSEC:0001601830-24-000247:0
About Taylor Ben R
Taylor Ben R is Chief Financial Officer at Recursion Pharmaceuticals, INC. He has 18 filings in total. Among the 18 sampled filings, sell transactions total EUR 75922, buy transactions total EUR 0, and the period runs from 2024-12-18 to 2026-04-08. The most common transaction nature is Retenue fiscale.